feed,title,long_url,short_url
Benzinga,"AstraZeneca COVID-19 Vaccine Candidate Moves Into Late-Stage US Clinical Trials With 30,000 Participants",https://www.benzinga.com/general/biotech/20/09/17322015/astrazeneca-covid-19-vaccine-candidate-moves-into-late-stage-us-clinical-trials-with-30-000-parti,https://j.mp/3lyzxIS
Benzinga,Strengthened patent protection for arfolitixorin in Japan,https://www.benzinga.com/pressreleases/20/09/n17322766/strengthened-patent-protection-for-arfolitixorin-in-japan,https://j.mp/2ETPIPY
